Regression of left ventricular hypertrophy: new hope for dying hearts.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Circulation

• Publication date

  1998-08-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.98.7.623PMID 9715852
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE EFFECT OF CARVEDILOL ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE

  2000cited by this paper
• Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle. Part II: Hypertrophy and dilatation of the failing heart.

  1998cited by this paper
• Regression of cellular hypertrophy after left ventricular assist device support.

  1998cited by this paper
• Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.

  1997cited by this paper
• Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease

  1997cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Fiolan International Randomized Survival Trial (FIRST): Final results

  1996cited by this paper
• Meeting Highlights American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996

  1996cited by this paper
• Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy

  1996cited by this paper
• Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.

  1995cited by this paper
• Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure.

  1995cited by this paper
• Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade.

  1995cited by this paper
• Cardiac Remodeling in Congestive Heart Failure

  1994cited by this paper
• The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.

  1993cited by this paper
• The paradox of β-adrenergic blockade for the management of congestive heart failure

  1992cited by this paper
• The paradox of beta-adrenergic blockade for the management of congestive heart failure.

  1992cited by this paper
• Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.

  1991cited by this paper
• New therapeutic strategies in chronic heart failure: challenge of long-term beta-blockade.

  1991cited by this paper
• Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

  1991cited by this paper
• DILITIZEM INCREASES LATE-ONSET CONGESTIVE HEART FAILURE IN POSTINFARCTION PATIENTS WITH EARLY REDUCTION IN EJECTION FRACTION

  1991cited by this paper
• Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure.

  1990cited by this paper
• Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.

  1990cited by this paper
• Xamoterol in severe heart failure.

  1990cited by this paper
• Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.

  1988cited by this paper
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study

  1987cited by this paper
• Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

  1986cited by this paper
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

  1986cited by this paper
• On the mechanism of compensatory hyperfunction and insufficiency of the heart.

  1961cited by this paper
• On the mechanism of compensatory hyperfunction and insufficiency of the heart.

  1961cited by this paper
• RADIOLOGY AS A DIAGNOSTIC AID IN CLINICAL SURGERY

  1960cited by this paper
• Disorders of motility and muscle tone with special reference to the corpus striatum

  year unknowncited by this paper

• Papel del estrés oxidativo y nitrosativo en la hipertrofia cardiaca y remodelación ventricular

  2019cites this paper
• Tocotrienol is a cardioprotective agent against ageing-associated cardiovascular disease and its associated morbidities

  2018cites this paper
• Effect of Renin-Angiotensin Blockers on Left Ventricular Remodeling in Severe Aortic Stenosis.

  2017cites this paper
• Factors Contributing to Development and Reversal of LVH: A Pilot Study.

  2016cites this paper
• Substance P Inhibits the Collagen Synthesis of Rat Myocardial Fibroblasts Induced by Ang II

  2016cites this paper
• Evidence for distinct effects of exercise in different cardiac hypertrophic disorders.

  2015cites this paper
• Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults

  2015cites this paper
• Inhibition of Angiotensin II-Induced Cardiac Hypertrophy and Associated Ventricular Arrhythmias by a p21 Activated Kinase 1 Bioactive Peptide

  2014cites this paper
• Which Therapy for Which Condition

  2009cites this paper
• Atrial and Brain Natriuretic Peptide and Endothelin-1 Concentration in Patients with Idiopathic Arterial Hypertension: The Dependence on the Selected Morphological Parameters

  2007cites this paper
• ROLE OF INDAPAMIDE ON HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY

  2006cites this paper
• Controversies in ventricular remodelling.

  2006cites this paper
• Cardiac Myocyte Structural Remodeling

  2005cites this paper
• Using genotyping to predict responses to anti-hypertensive treatment.

  2005cites this paper
• Is an Intracrine Renin-Angiotensin System Involved in the Control of Cardiovascular Function?

  2003cites this paper
• Left Ventricular Hypertrophy in Hypertension

  2002cites this paper
• 高齢者に対する carvedilol の心血行動態に及ぼす作用と忍容性の検討

  2002cites this paper
• Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments.

  2002cites this paper
• Left Ventricular Hypertrophy in Hypertension

  2002cites this paper
• Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.

  2001cites this paper
• Fatores prognósticos e evolução da função ventricular em 5 anos de seguimento da ventriculectomia parcial esquerda no tratamento da cardiomiopatia dilatada

  2001cites this paper
• Effects of Antihypertensive Agents on the Left Ventricle

  2001cites this paper
• Therapeutic potential of Na-H exchange inhibitors for the treatment of heart failure

  2001cites this paper
• p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta -adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation.

  2000cites this paper
• p38 Mitogen-activated Protein Kinase Pathway Protects Adult Rat Ventricular Myocytes against β-Adrenergic Receptor-stimulated Apoptosis

  2000cites this paper
• Genetic contributions to left ventricular hypertrophy

  2000cites this paper
• Hypertrophy and Hypertension

  1999cites this paper
• Heart failure development in aortic valve insufficiency.

  1999cites this paper
• Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen

  1999cites this paper